{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:21:30Z","timestamp":1787570490775,"version":"build-2736575974"},"reference-count":21,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2026,3,28]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Asbestosis is a progressive interstitial lung disease caused by inhalation of asbestos fibres. Although asbestos use was banned in the Netherlands in 1993, new cases continue to be diagnosed. Since 2014, a national compensation system has enabled systematic assessment of asbestosis incidence and outcomes. This population-based study examined national trends in asbestosis incidence from 2014\u20132024 and evaluated survival and prognostic factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective national cohort study including all adults (\u226518\u2005years) diagnosed with asbestosis between 2014\u20132024 according to Dutch Health Council criteria used for compensation. Diagnoses were established by consensus of three independent pulmonologists based on radiological evidence of diffuse pulmonary fibrosis, \u22655 fibre-years of exposure, and lung function impairment according to American Medical Association (AMA) criteria. Demographic data, lung function, work history and overall survival were collected. Incidence per 100\u2009000 persons per year was calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1004 applicants, 476 (47.4%) met criteria for asbestosis. Median age at diagnosis was 77\u2005years, and 98.9% were male. Annual incidence ranged from 0.115 to 0.347 per 100\u2009000, with no significant temporal trend (Spearman rho 0.41; p=0.214). AMA class 4 was most common (44.5%) and strongly associated with mortality (hazard ratio 2.52, 95% CI 1.81\u20133.49). Older age also predicted poorer survival. Median survival ranged from 25.5\u2005months (AMA 4) to 83.4\u2005months (AMA 0\u20132). Time-dependent modelling showed increasing hazard over time for AMA class 4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>More than two decades after the asbestos ban, asbestosis incidence remains stable. AMA class and age are key predictors of survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.01715-2025","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:10:18Z","timestamp":1785406218000},"page":"01715-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology of asbestosis in the Netherlands: a 10-year cohort analysis"],"prefix":"10.1183","volume":"12","author":[{"given":"Illaa","family":"Smesseim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Schouwink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Grutters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4233-1890","authenticated-orcid":false,"given":"Hans","family":"Kromhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Heederik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus A.","family":"Burgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"2026082403352835000_12.4.01715-2025.1","doi-asserted-by":"publisher","DOI":"10.5271\/sjweh.3462"},{"key":"2026082403352835000_12.4.01715-2025.2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-214822"},{"key":"2026082403352835000_12.4.01715-2025.3","first-page":"1","article-title":"Epidemiology of asbestosis between 2010\u20132014 and 2015\u20132019 periods in Colombia: descriptive study","volume":"89","author":"Camero","year":"2023","journal-title":"Ann Glob Health"},{"key":"2026082403352835000_12.4.01715-2025.4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.path.2010.04.003","article-title":"Asbestos-related lung disease","volume":"3","author":"Attanoos","year":"2010","journal-title":"Surg Pathol Clin"},{"key":"2026082403352835000_12.4.01715-2025.5","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1998.8472"},{"key":"2026082403352835000_12.4.01715-2025.6","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1158\/2767-9764.CRC-23-0423","article-title":"Low exposures to amphibole or serpentine asbestos in germline bap1-mutant mice induce mesothelioma characterized by an immunosuppressive tumor microenvironment","volume":"4","author":"Kadariya","year":"2024","journal-title":"Cancer Res Commun"},{"key":"2026082403352835000_12.4.01715-2025.7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1179\/oeh.2008.14.3.161","article-title":"Asbestosis mortality surveillance in the United States, 1970-2004","volume":"14","author":"Bang","year":"2008","journal-title":"Int J Occup Environ Health"},{"key":"2026082403352835000_12.4.01715-2025.8","doi-asserted-by":"publisher","DOI":"10.5858\/134.3.462"},{"key":"2026082403352835000_12.4.01715-2025.9","first-page":"15","article-title":"Helsinki Criteria update 2014: asbestos continues to be a challenge for disease prevention and attribution","volume":"40","author":"Vainio","year":"2016","journal-title":"Epidemiol Prev"},{"key":"2026082403352835000_12.4.01715-2025.10","unstructured":"AMA . AMA guides to the evaluation of permanent impairment: an overview. Date last accessed: 10 January 2026. Date last updated: 4th December 2025. www.ama-assn.org\/practice-management\/ama-guides\/ama-guides-evaluation-permanent-impairment-overview"},{"key":"2026082403352835000_12.4.01715-2025.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jenvman.2022.115716"},{"key":"2026082403352835000_12.4.01715-2025.12","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217709"},{"key":"2026082403352835000_12.4.01715-2025.13","unstructured":"Nederlandse Arbeidsinspectie . Wet-en regelgeving asbest. Date last accessed: 13 January 2026. Date last updated: 13 January 2026. www.nlarbeidsinspectie.nl\/onderwerpen\/asbest\/wet--en-regelgeving-asbest"},{"key":"2026082403352835000_12.4.01715-2025.14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/ajim.23629","article-title":"Asbestos exposure and asbestosis mortality in Italian cement-asbestos cohorts: dose-response relationship and the role of competing death causes","volume":"67","author":"Girardi","year":"2024","journal-title":"Am J Ind Med"},{"key":"2026082403352835000_12.4.01715-2025.15","first-page":"674","article-title":"A simple method for detecting asbestos in tissue","volume":"20","author":"Gold","year":"1967","journal-title":"J Clin Pathol"},{"key":"2026082403352835000_12.4.01715-2025.16","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.26.3.224"},{"key":"2026082403352835000_12.4.01715-2025.17","doi-asserted-by":"publisher","DOI":"10.1258\/rsmmsl.44.2.151"},{"key":"2026082403352835000_12.4.01715-2025.18","doi-asserted-by":"crossref","unstructured":"Gezondheidsraad . Protocollen asbestziekten: asbestose. Date last accessed: 13 January 2026. Date last updated: 29 March 1999. www.gezondheidsraad.nl\/documenten\/adviezen\/1999\/03\/29\/protocollen-asbestziekten-asbestose","DOI":"10.7748\/ns.13.42.29.s46"},{"key":"2026082403352835000_12.4.01715-2025.19","first-page":"D544","article-title":"[Financial compensation for asbestosis patients]","volume":"160","author":"Hagmolen Of Ten Have","year":"2016","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2026082403352835000_12.4.01715-2025.20","unstructured":"ALEA Productions . Date last accessed: 13 January 2026. Date last updated: 13 January 2026. https:\/\/prod.tenalea.net\/drup\/dm\/DELogin.aspx?refererPath=DEHome.aspx"},{"key":"2026082403352835000_12.4.01715-2025.21","doi-asserted-by":"crossref","first-page":"25677","DOI":"10.1038\/s41598-025-10054-6","article-title":"Pleural mesothelioma incidence and use of systemic treatment decreased during the COVID-19 pandemic in The Netherlands","volume":"15","author":"Smesseim","year":"2025","journal-title":"Sci Rep"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.01715-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:35:38Z","timestamp":1787567738000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.01715-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,24]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1183\/23120541.01715-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.01715-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}